Yonsei University
🇰🇷South Korea
- Country
- 🇰🇷South Korea
- Ownership
- Private
- Established
- 1885-01-01
- Employees
- 5K
- Market Cap
- -
- Website
- http://www.yonsei.ac.kr
A Study for Identification of Immune Determinants for Response to Nivolumab in Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma
- First Posted Date
- 2020-10-26
- Last Posted Date
- 2022-02-11
- Lead Sponsor
- Yonsei University
- Target Recruit Count
- 50
- Registration Number
- NCT04603248
- Locations
- 🇰🇷
Yonsei Severance Hospital, Seoul, Korea, Republic of
Effect of Intraoperative Iloprost Inhalant on Hemodynamic Stability in Patients Undergoing Off-pump Coronary Artery Bypass Graft Surgery
Not Applicable
- Conditions
- Coronary Artery Occlusive Disease
- Interventions
- Drug: Control (Normal saline)
- First Posted Date
- 2020-10-22
- Last Posted Date
- 2020-11-05
- Lead Sponsor
- Yonsei University
- Target Recruit Count
- 100
- Registration Number
- NCT04598191
- Locations
- 🇰🇷
Yonsei Severance Hospital, Seoul, Korea, Republic of
CDK4/6 Tumor, Abemaciclib, Paclitaxel
Phase 1
Completed
- Conditions
- Tumors
- Interventions
- Drug: abemaciclib+paclitaxel
- First Posted Date
- 2020-10-20
- Last Posted Date
- 2024-12-18
- Lead Sponsor
- Yonsei University
- Target Recruit Count
- 30
- Registration Number
- NCT04594005
- Locations
- 🇰🇷
Severance Hospital, Seoul, Korea, Republic of
Pembrolizumab, Olaparib, Recurrent/Advanced Gastric and Gastro-esophageal Junction(GEJ) Cancer
Phase 1
Recruiting
- Conditions
- Gastric Cancer Stage IV
- Interventions
- Drug: olaparib+pembrolizumab+paclitaxel
- First Posted Date
- 2020-10-19
- Last Posted Date
- 2025-01-24
- Lead Sponsor
- Yonsei University
- Target Recruit Count
- 71
- Registration Number
- NCT04592211
- Locations
- 🇰🇷
Severance Hospital, Seoul, Korea, Republic of
HIV Pre-exposure Prophylaxis Implementation Study in South Korea
Not Applicable
- Conditions
- HIV Infections
- Interventions
- First Posted Date
- 2020-10-12
- Last Posted Date
- 2020-10-12
- Lead Sponsor
- Yonsei University
- Target Recruit Count
- 200
- Registration Number
- NCT04583267
- Locations
- 🇰🇷
Yonsei Severance Hospital, Seoul, Korea, Republic of
Clinical Trials to Compare the Effects of Pioglitazone and Evogliptin on Hepatic Fibrosis in Patients With Chronic Hepatitis B With Significant Hepatic Fibrosis With Type 2 Diabetes
Phase 4
- Conditions
- Chronic Hepatitis B With Significant Hepatic Fibrosis With Type 2 Diabetes
- Interventions
- Drug: suganon tab 5mgDrug: gluconon tab 15mg
- First Posted Date
- 2020-10-12
- Last Posted Date
- 2020-10-12
- Lead Sponsor
- Yonsei University
- Target Recruit Count
- 40
- Registration Number
- NCT04584242
- Locations
- 🇰🇷
Gangnam Severance Hospital, Seoul, Korea, Republic of
🇰🇷Samsung Hospital, Seoul, Korea, Republic of
🇰🇷Seoul National University Hospital, Seoul, Korea, Republic of
Effects of Iloprost on Pulmonary Oxygenation in Obese Patients During One-lung Ventilation
Not Applicable
- Conditions
- Pulmonary InfectionLung Cancer (Including Metastatic Cancer)
- Interventions
- Drug: normal saline inhalation
- First Posted Date
- 2020-10-12
- Last Posted Date
- 2020-10-12
- Lead Sponsor
- Yonsei University
- Target Recruit Count
- 78
- Registration Number
- NCT04583046
The Role of Hepcidin as a Biomarker to Predict Successful Renal Transplantation
- Conditions
- End-stage Renal Disease
- First Posted Date
- 2020-10-05
- Last Posted Date
- 2020-10-05
- Lead Sponsor
- Yonsei University
- Target Recruit Count
- 200
- Registration Number
- NCT04575077
- Locations
- 🇰🇷
Yonsei Severance Hospital, Seoul, Korea, Republic of
Prognostic Value of Soluble Urokinase-type Plasminogen Activator Receptor in Valvular Heart Disease
- Conditions
- Severe Aortic Stenosis or Severe Aortic Regurgitation
- First Posted Date
- 2020-10-01
- Last Posted Date
- 2020-11-30
- Lead Sponsor
- Yonsei University
- Target Recruit Count
- 250
- Registration Number
- NCT04571372
- Locations
- 🇰🇷
Division of Cardiology, Severance Cardiovascular Hospital, Yonsei University College of Medicine, Seoul, Korea, Republic of
Comparison of the Impacts of Sugammadex With Neostigmine on Patency of Laryngeal Opening (Glottic Aperture Angle)
Not Applicable
- Conditions
- Supraglottic Airway Device Insertion
- Interventions
- First Posted Date
- 2020-09-10
- Last Posted Date
- 2020-09-10
- Lead Sponsor
- Yonsei University
- Target Recruit Count
- 84
- Registration Number
- NCT04545099
© Copyright 2025. All Rights Reserved by MedPath